Showing results (171-180 of 243) with videos related to
Sort By:
Pageof 25
Lancet (London, England)|October 6, 1998
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classificationP W Wahl, P J Savage, B M Psaty, et al.American Journal of Epidemiology|January 15, 1996
Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal womenE N Meilahn, J A Cauley, R P Tracy, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1990
Heterogeneity of human boneJ T Ninomiya, R P Tracy, J D Calore, et al.Thrombosis and Haemostasis|June 3, 1998
Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health StudyM Cushman, F R Rosendaal, B M Psaty, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 24, 2001
The relation of body fat mass and distribution to markers of chronic inflammationA Festa, R D'Agostino, K Williams, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) studyM L Stefanick, C Legault, R P Tracy, et al.Diabetes|September 28, 2001
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health StudyJ I Barzilay, L Abraham, S R Heckbert, et al.Arthritis and Rheumatism|January 27, 1999
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosusS Manzi, F Selzer, K Sutton-Tyrrell, et al.Circulation|November 1, 1993
Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research GroupT A Manolio, C D Furberg, L Shemanski, et al.The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trialB W Walsh, S Paul, R A Wild, et al.Pageof 25